http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104758289-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 |
| filingDate | 2015-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104758289-B |
| titleOfInvention | A kind of compound antihypertensive drug combination and its application containing medetofazone |
| abstract | The present invention provides a kind of pharmaceutical composition for treating hypertension, includes: (1) calcium-channel antagonists in the pharmaceutical composition；(2) diuretics medetofazone；(3) pharmaceutically acceptable auxiliary material.Wherein the weight ratio of calcium-channel antagonists and medetofazone is 1~40:0.1~2.The two combination, reinforces Synergistic Hypotensive Effects, reduces adverse reaction, improves the compliance of patient, and medication crowd is wide, is particularly suitable for the patient of kidney function damage, and is not susceptible to diuretics resistance. |
| priorityDate | 2015-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.